https://techpapersworld.com/wp-content/uploads/2024/11/Fall-2024-Leapfrog-Hospital-1280x720.jpg

The Leapfrog Group, an independent nonprofit focused on patient safety, today released its fall 2024 Hospital Safety Grade, evaluating nearly 3,000 hospitals on their ability to prevent medical errors, accidents and infections. The Hospital Safety Grade uses up to 30 performance measures to assign an “A, “B,” “C,” “D” or “F” to individual hospitals and uses a public, peer-reviewed methodology, calculated by top patient safety experts under the guidance of a National Expert Panel. It is...

https://techpapersworld.com/wp-content/uploads/2024/11/New-Campaign-Aims-to-Improve-Early-1280x720.jpg

Each year, 500 to 1,000 people in the U.S. are diagnosed with pulmonary arterial hypertension (PAH), a progressive and often under-detected disease. To address the significant impact of this disease and improve awareness and resources for those affected, the American Lung Association, with support from Merck, is launching a new educational campaign. Pulmonary arterial hypertension (PAH) is a specific form of pulmonary hypertension, characterized by high blood pressure in the lungs due to obstruction in the small...

https://techpapersworld.com/wp-content/uploads/2024/11/Dr.-Abhijit-Patel-Receives-2024-1280x720.jpg

LUNGevity Foundation and Rising Tide Foundation for Clinical Cancer Research are proud to support Abhijit Patel, MD, PhD, Yale University School of Medicine, with the 2024 Rising Tide Foundation for Clinical Cancer Research / LUNGevity Foundation Lung Cancer Early Detection Award to dramatically reduce lung cancer-related mortality. Dr. Patel and his close collaborator, Steven Skates, PhD, at Massachusetts General Hospital, have developed an exciting technical breakthrough that accurately measures tiny amounts of DNA fragments from cancer cells that...

https://techpapersworld.com/wp-content/uploads/2024/11/Sg2-Data-Highlights-Urgency-for-Increased-1280x720.jpg

Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and related challenge of timely patient access to lifesaving interventions such as transcatheter aortic valve replacement (TAVR) procedures. The paper, “The Rising Tide of Cardiovascular Disease: A Looming Crisis for Cardiovascular Intervention Resources” notes an 8% increase in demand for inpatient procedures and a 25% increase for outpatient procedures over the next 10 years. “Hospitals struggling...

https://techpapersworld.com/wp-content/uploads/2024/11/ImageBiopsy-Lab-launches-1280x720.jpg

ImageBiopsy Lab, a leading provider of AI-powered musculoskeletal imaging solutions, has launched IB Lab FROG. This AI module, CE-cleared under the European Medical Device Regulation (MDR) standards, offers a comprehensive suite of automated measurements on X-rays, designed for radiological and orthopedic foot assessments. IB Lab FROG covers key foot pathologies and delivers clinicians accurate, standardized data for diagnosing and managing foot disorders. New – by ImageBiopsy Lab Foot pathologies are prevalent in 61%-79% of the population,...

https://techpapersworld.com/wp-content/uploads/2024/11/EDAN-Unveils-Latest-Innovations-1280x720.jpg

Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its latest product innovations at MEDICA 2024 in Germany. The event, held from November 11 to 14, attracted over 83,000 attendees and 5,300 exhibitors, highlighting advancements in healthcare technology. “Approaching its 30th anniversary, EDAN’s presence this year underscores our commitment to practical, adaptable healthcare solutions for real-world challenges,” said Brian He, Senior regional sales director of EDAN. “Our latest innovations are shaped by constant feedback...

https://techpapersworld.com/wp-content/uploads/2024/11/While-More-Is-Better-Even-1280x720.jpg

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11%, a new study shows. Led by researchers at NYU Langone Health, the investigation focused on atrial fibrillation, a condition in which the heart’s upper two chambers beat rapidly and irregularly instead of at a consistent pace. If left untreated, this can lead to stroke, heart failure, and other issues. While...

https://techpapersworld.com/wp-content/uploads/2023/11/AI-Identifies-Non-smokers-1280x720.jpg

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of sunvozertinib for the treatment of  locally advanced or metastatic non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins), as detected by an FDA-approved test, whose disease has progressed on...

https://techpapersworld.com/wp-content/uploads/2024/11/Groupe-Mutuel-integrates-Ada-Health-1-1280x720.jpg

Ada Health, the leading global AI health assessment and care navigation platform, and Groupe Mutuel, the comprehensive insurer, have launched a partnership to support quicker and easier access to affordable, effective care for up to 1.4 million Groupe Mutuel members across Switzerland. Through this partnership, Ada’s clinically validated AI helps Groupe Mutuel offer tailored healthcare experiences for their members. For these members, Ada’s on-demand, trustworthy health assessments support them by navigating them to a wide array of...

https://techpapersworld.com/wp-content/uploads/2024/11/Oxford-Nanopore-Announces-Landmark-UK-Government-1280x720.jpg

Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a landmark strategic partnership with the UK Government. This partnership brings together the UK’s world-class scientific organisations Genomics England, UK Biobank and NHS England, alongside Oxford Nanopore, to support the government’s vision to build an NHS “fit for the future” by enabling genomics-based translational research and accelerating the development and adoption of Oxford Nanopore’s ground-breaking genomics technology in the NHS....